Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...
News-Medical.Net on MSN
New exercise-sensing pathway offers hope for osteoporosis treatment
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...
Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP ...
Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...
LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...
NewcelX ( ($NCEL) ) has provided an update. On January 5, 2026, NewcelX Ltd. announced the appointment of Dr. Julien Boisdron, a veteran diabetes ...
Longer-term results from the BENEFIT trial show sustained minimal residual disease negativity in newly diagnosed, ...
A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...
LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology ...
Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readinessCompany on track to initiate ...
Thomas Wiggans appointed Executive Chairperson Jasper to host an investor webinar on January 8th at 8:00am ET to present updated data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback